Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Adenocarcinoma and HGF[original query] |
---|
Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 May 5 (5): 591-6. Onitsuka Takamitsu, Uramoto Hidetaka, Ono Kenji, Takenoyama Mitsuhiro, Hanagiri Takeshi, Oyama Tsunehiro, Izumi Hiroto, Kohno Kimitoshi, Yasumoto Kos |
Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma. Medical science monitor : international medical journal of experimental and clinical research 2016 22 276-83. He Yayi, Wang Yan, Boyle Theresa, Ren Shengxiang, Chan Dan, Rivard Chris, Li Xuefei, Li Jiayu, Zhou Caicun, Hirsch Fred |
MET amplification, protein expression, and mutations in pulmonary adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2015 Dec 90 (3): 381-7. Park Seongyeol, Koh Jaemoon, Kim Dong-Wan, Kim Miso, Keam Bhumsuk, Kim Tae Min, Jeon Yoon Kyung, Chung Doo Hyun, Heo Dae Se |
Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge. Oncology letters 2017 Jun 13 (6): 4939-4946. Nakamura Tomomi, Watanabe Naomi, Sato Akemi, Komiya Kazutoshi, Umeguchi Hitomi, Hosomi Toshiya, Hirai Mitsuharu, Sueoka Eisaburo, Kimura Shinya, Sueoka-Aragane Nao |
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer. Cancer 2017 Aug 123 (15): 2936-2944. Tarhini Ahmad A, Rafique Imran, Floros Theofanis, Tran Phu, Gooding William E, Villaruz Liza C, Burns Timothy F, Friedland David M, Petro Daniel P, Farooqui Mariya, Gomez-Garcia Jose, Gaither-Davis Autumn, Dacic Sanja, Argiris Athanassios, Socinski Mark A, Stabile Laura P, Siegfried Jill |
Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer-associated fibroblasts with EGFR-TKI resistance-promoting phenotype: A study of 18 cases of cancer-associated fibroblasts. Pathology international 2019 7 69 (8): 472-480. Suzuki Erika, Yamazaki Shota, Naito Tomoyuki, Hashimoto Hiroko, Okubo Satoshi, Udagawa Hibiki, Goto Koichi, Tsuboi Masahiro, Ochiai Atsushi, Ishii Genichi |
Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach. Cellular oncology (Dordrecht) 2023 11 . Jingtao Wei, Ke Ji, Yue Zhang, Ji Zhang, Xiaojiang Wu, Xin Ji, Kai Zhou, Xuesong Yang, Hongfeng Lu, Anqiang Wang, Zhaode |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: